期刊文献+

肥厚型心肌病的基因型与表型分析 被引量:9

A research on the relationship of genotypes and phenotypes in hypertrophic cardiomyopathy
原文传递
导出
摘要 目的应用全外显子测序(WES)和三维斑点追踪超声心动图(3D-STE)技术探讨肥厚型心肌病(HCM)患者的基因型与表型间的关系。方法选取2018年6月至2019年1月复旦大学附属中山医院的HCM患者45例,并按心尖是否肥厚分为心尖肥厚型心肌病组(ApHCM组,20例)和非心尖肥厚型心肌病组(non-ApHCM组,25例)。采集HCM患者的静脉血进行WES测序。利用常规二维超声心动图测量室间隔厚度、左室后壁厚度、左室舒张末内径、左室收缩末内径、左室壁最大厚度和左室射血分数(LVEF),并采集标准心尖四腔心的全容积图像,应用3D-STE脱机分析,获得左心室整体纵向应变(GLS)、整体环向应变(GCS)、扭转和扭矩。并分析以上参数、基因突变与左室形态学的相关性。结果HCM患者携带基因突变的比例为73%,其中MYBPC3和MYH7基因的突变最多,分别占全部突变的18%和15%。ApHCM组和non-ApHCM组的基因检测结果均发现KCNEc.79C>T(p.Arg27Cys)和PRKAG2c.905G>A(p.Arg302Gln)突变。ApHCM组基因突变阳性的比例显著低于non-ApHCM组(60%对84%,P=0.041)。ApHCM组GLS显著大于non-ApHCM组(P=0.008)。突变阳性与突变阴性的HCM患者比较,GLS差异无统计学意义(P=0.068)。GLS与左室形态学(ApHCM和non-ApHCM)分类呈中等程度相关(r=0.364,P=0.012),而与是否携带基因突变无相关性(r=0.269,P=0.062)。结论HCM的遗传和表型间存在复杂多样的对应关系。ApHCM和non-ApHCM在基因突变和收缩功能上明显不同。GLS的大小与左室形态相关,而与基因突变无相关性。 Objective To explore the relationship between genotypes and phenotypes in hypertrophic cardiomyopathy(HCM)patients using whole exome sequencing(WES)and three-dimensional speckle-tracking echocardiography(3D-STE).Methods Twenty patients with apical HCM(ApHCM)and 25 patients with non-apical HCM(non-ApHCM)from June 2018 to January 2019 in Zhongshan Hospital of Fudan University were enrolled.All subjects underwent venous blood sampling and WES.Regular two-dimensional echocardiography was performed to acquire the following parameters:interventricular septum thickness,left ventricular posterior wall thickness,left ventricular end diastolic diameter,left ventricular end systolic diameter,the maximum thickness of left ventricular walls and left ventricular ejection fraction(LVEF).Full volume images were collected and then off-time analyzed with 3D-STE to acquire global longitudinal strain(GLS),global circumferential strain(GCS),twist and torsion.The relationships between above parameters,genotypes and phenotypes of left ventricle were analyzed.Results Mutations were found in 73%of HCM patients.The two most common genes MYBPC3 and MYH7 accounted for 18%and 15%of mutations respectively.KCNEc.79C>T(p.Arg27Cys)and PRKAG2c.905G>A(p.Arg302Gln)were detected in both ApHCM group and non-ApHCM group.In ApHCM group,60%of patients carried genetic mutations,which was significantly lower than non-ApHCM group(84%)(P=0.041).Compared with non-ApHCM group,GLS in ApHCM group was significantly higher(P=0.008).There was no statistical difference of GLS between patients with mutations and without mutations(P=0.068).GLS demonstrated a moderate correlation with morphologic types of HCM(ApHCM and non-ApHCM)(r=0.364,P=0.012).However,there was no correlation between GLS and the condition of mutations(r=0.269,P=0.062).Conclusions The relationship between genetics and phenotypic expression of HCM appears to be complex and heterogeneous.There are marked differences in gene mutations and systolic functions between ApHCM and non-ApHCM.The value of GLS correlates with the shape of left ventricle but not with genotypes.
作者 唐璐 周年伟 蒋英英 李雪洁 孙敏敏 潘翠珍 舒先红 Tang Lu;Zhou Nianwei;Jiang Yingying;Li Xuejie;Sun Minmin;Pan Cuizhen;Shu Xianhong(Department of Echocardiography,Zhongshan Hospital of Fudan University,Shanghai 200032,China)
出处 《中华超声影像学杂志》 CSCD 北大核心 2020年第3期219-223,共5页 Chinese Journal of Ultrasonography
基金 上海市科学技术委员会科研计划项目(17411954400)。
关键词 超声心动描记术 三维 斑点追踪显像 肥厚型心肌病 基因突变 应变 Echocardiography three-dimensional Speckle tracking imaging Hypertrophic cardiomyopathy Mutations Strain
  • 相关文献

参考文献6

二级参考文献37

  • 1廉哲勋,陈红磊,王永彬,蔡尚郎.肥厚型心肌病冠状动脉血流动力学相关参数变化[J].青岛大学医学院学报,2005,41(2):109-111. 被引量:1
  • 2Maron BJ, McKenna WJ. Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines[J]. Eur Heart J,2003,24(21): 1965-1091.
  • 3Harris KM, Spirito P, Maron MS, et al. Prevalence.clinical profile,and significance of left vemrieular remodeling in the end stage phase of hypertrophic cardiomyopathy [ J ]. Circulation,2006,114(3) :216-225.
  • 4Maron MS, Olivotto I, Zenovieh AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction[J].Circulation, 2006, 114(21) 2232- 2239.
  • 5Lee CH, Liu PY, Lin I.J, et al. Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan[J]. Cardiology,2006,106(1 ) :29 -35.
  • 6Cecchi F, Olivotto I, Gistrl R. el al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy [J].N Engl J Med. 2003, 349(11):1027- 1035.
  • 7Pieroni M, Bellocci F, Sanna T, et al. Increased brain natriuretlc peptide secretion is a marker of disease progression in nonobstmetive hypertrophic cardiomyopathy[J]. J Card Fail, 2007,13(5) :380 -388.
  • 8Nagakura T, Takeuchi M, Yoshitani H, et al. Hypertrophic cardiomyopathy is associat- ed with more severe left ventricular dyssynchro- ny than is hypertensive left ventricular hypertro- phy [ J ]. Echocardiography, 2007, 24(7) : 677 - 684.
  • 9Araujo AQ, Arteaga E, Ianni BM, et al. Usefulness of a new proposed tissue doppler imaging global function index in hypertrophic cardiomyopathy [ J ]. Echocardiography, 2006, 23 (3): 197-201.
  • 10Hudburt HM, Aurigemma GP, Gaasch WH, et al. Direct ultrasound measurement of the 3 principal components of left ventrieular regional systolic strain [ J]. J Am Coil Cardiol, 2006, 47: 116.

共引文献45

同被引文献71

引证文献9

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部